Increased Morbidity in Males Diagnosed With Gynecomastia: A Nationwide Register-based Cohort Study.
endocrinology
epidemiology
gynecomastia
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
16 Jun 2023
16 Jun 2023
Historique:
received:
07
12
2022
pmc-release:
31
01
2024
medline:
19
6
2023
pubmed:
1
2
2023
entrez:
31
1
2023
Statut:
ppublish
Résumé
Evidence on the long-term and general health of males with gynecomastia is lacking. To assess health before and following a diagnosis of gynecomastia. A register-based cohort study of 140 574 males, of which 23 429 were diagnosed with incident gynecomastia and age- and calendar-matched (1:5) to 117 145 males without gynecomastia from the background population. Males with gynecomastia were stratified into males without (idiopathic) or with a known preexisting risk factor (disease/medication). Cox and logistic regression models investigated associations of disease risk according to International Classification of Diseases 10th revision sections following and before gynecomastia diagnosis. A total of 16 253 (69.4%) males in the cohort were identified with idiopathic gynecomastia. These males had a statistically significant higher risk of future disease across all included disease chapters (hazard ratio [HR], 1.19-1.89), with endocrine diseases representing the greatest disease risk (HR, 1.89; 95% CI, 1.76-2.03). The highest subchapter disease risk was observed for disorders of the endocrine glands (odds ratio [OR], 7.27; 95% CI, 6.19-8.54). Similarly, the ORs of comorbidities were higher across all included disease sections (OR, 1.05-1.51), except for psychiatric disease (OR, 0.72; 95% CI, 0.68-0.78), with the highest association with musculoskeletal/connective tissue (OR, 1.51; 95% CI, 1.46-1.57) and circulatory (OR, 1.36; 95% CI, 1.29-1.43) diseases. The presence of idiopathic gynecomastia is an important first clinical symptom of an underlying disease and a significant predictor of future disease risk. These findings should stimulate more awareness among health care providers to increase identification of gynecomastia and its causes in males.
Identifiants
pubmed: 36718997
pii: 7016774
doi: 10.1210/clinem/dgad048
pmc: PMC10271232
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e380-e387Subventions
Organisme : NCI NIH HHS
ID : R01 CA236816
Pays : United States
Organisme : NIH HHS
ID : 1R01CA236816-01A1
Pays : United States
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Am J Med. 1984 Oct;77(4):633-8
pubmed: 6486139
Int J Epidemiol. 2017 Jun 1;46(3):798-798f
pubmed: 27789670
Scand J Public Health. 2011 Jul;39(7 Suppl):42-5
pubmed: 21775350
Psychosom Med. 1962 Jul-Aug;24:379-89
pubmed: 13909166
Scand J Public Health. 2011 Jul;39(7 Suppl):12-6
pubmed: 21898916
Acad Radiol. 2018 May;25(5):626-635
pubmed: 29326049
J Clin Endocrinol Metab. 2020 Oct 1;105(10):
pubmed: 32710775
Andrology. 2019 Nov;7(6):778-793
pubmed: 31099174
Scand J Public Health. 2021 Jul;49(5):555-562
pubmed: 33280527
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
Clin Endocrinol (Oxf). 1990 Jan;32(1):101-5
pubmed: 2331807
N Engl J Med. 2007 Sep 20;357(12):1229-37
pubmed: 17881754
J Clin Endocrinol Metab. 2023 Jun 16;108(7):e380-e387
pubmed: 36718997
J Clin Endocrinol Metab. 2022 May 17;107(6):1560-1568
pubmed: 35225342
Pediatr Res. 2002 Nov;52(5):682-6
pubmed: 12409513
J Clin Endocrinol Metab. 2020 Oct 1;105(10):
pubmed: 32754750
J Clin Endocrinol Metab. 2015 Oct;100(10):3752-9
pubmed: 26287961
Body Image. 2015 Sep;15:141-8
pubmed: 26408934
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
Scand J Public Health. 2011 Jul;39(7 Suppl):38-41
pubmed: 21775349
Front Endocrinol (Lausanne). 2022 Dec 01;13:1048660
pubmed: 36531497
Indian J Endocrinol Metab. 2014 Mar;18(2):150-8
pubmed: 24741509
J Sex Med. 2009 Apr;6(4):989-1000
pubmed: 19175864